[CHRS] YoY Quarter Result on 30-Sep-2020 [#Q3]

Stock
[CHRS] Coherus BioSciences, Inc.
Announcement Date
05-Nov-2020
Financial Year
2020
Quarter
30-Sep-2020 [#Q3]
Profit Trend
QoQ- -52.68%
YoY- -40.62%
Quarter Report
CHRS's Result
CHRS's Financial Summary
View:
Show?
Quarter Result
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 CAGR
Revenue 74,568 45,424 82,503 113,551 111,684 0 0 -
PBT -40,021 -86,650 -38,528 28,116 47,890 -58,826 -58,993 -6.25%
Tax -380 6,201 5,801 183 847 2,978 2,402 -
NP -39,641 -92,851 -38,528 27,933 47,043 -58,808 -58,989 -6.40%
Tax Rate - - - -0.65% -1.77% - - -
Total Cost 114,209 138,275 121,031 85,618 64,641 58,808 58,989 11.63%
Ratio Analysis
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 CAGR
NP Margin -53.16 -204.41 -46.70 24.60 42.12 0.00 0.00 -
Per Share
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 CAGR
EPS -0.41 -1.19 -0.49 0.39 0.67 -0.87 -1.09 -15.03%
EPS Diluted -0.41 -1.19 -0.49 0.33 0.63 -0.87 -1.09 -15.03%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.